New Delhi, April 1 -- Health ministry on Wednesday notified GLP-1 (glucagon-like peptide-1 receptor agonists) drugs, which are prescribed to treat Type 2 Diabetes and obesity must be taken under medical supervision. The misuse of GLP-1 drugs without clinical oversight can lead to severe health complications.

The release also notified that there are various side-effects both mild and serious to taking GLP-1 drugs, including nausea and dizziness to pancreatitis and medullary thyroid cancer. Here's all you need to know about the risk, use and regulations about the drug.

When we eat, the body breaks food into simple sugars that enter the bloodstream. GLP-1 is activated in response signalling the pancreas to release insulin that helps move s...